Me
Meiji Pharma
Tokyo JPFounded 19467,000 employees
Private CappharmaPrivateInfectious DiseaseCNS
Platform: Meiact Antibiotic
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixacagene | MEI-7762 | Preclinical | 1 | PI3Kα | NSCLC | ||
| Pexatenlimab | MEI-7772 | Approved | 2 | EZH2 | Ewing Sarcoma | ||
| Tiravorutinib | MEI-2255 | Preclinical | 1 | GLP-1R | CRCGastric Ca | ||
| MEI-1324 | MEI-1324 | Preclinical | 2 | KRASG12C | FSGSSMA |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)